Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CD33 FPBMC |
| Synonyms | |
| Therapy Description |
Limited information is currently available on CD33 FPBMC, a putative preparation of CD3 and CD33 bispecific antibody-armed fresh peripheral blood mononuclear cells (Dec 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CD33 FPBMC | Limited information is currently available on CD33 FPBMC, a putative preparation of CD3 and CD33 bispecific antibody-armed fresh peripheral blood mononuclear cells (Dec 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07270978 | Phase I | CD33 FPBMC | Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS (AML-MDS 001) | Recruiting | USA | 0 |